Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enzymatic acetylation of fortimicin A and seldomycin factor 5 by aminoglycoside 3-acetyltransferase I: [AAC(3)-I] of E. coli KY8348.

× No keyword cloud information.

8 in total

1. Enzymatic modification of aminoglycoside antibiotics: 3-N-acetyltransferase with broad specificity that determines resistance to the novel aminoglycoside apramycin.

Authors: J Davies; S O'Connor
Journal: Antimicrob Agents Chemother Date: 1978-07 Impact factor: 5.191

2. In vitro and in vivo antibacterial activity of KW1070, a new aminoglycoside antibiotic.

Authors: Y Ohashi; H Kawabe; K Sato; N Nakamura; S Kurashige; S Mitsuhashi
Journal: Antimicrob Agents Chemother Date: 1980-02 Impact factor: 5.191

3. Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests.

Authors: C Thornsberry; A L Barry; R N Jones; C N Baker; R E Badal; R R Packer
Journal: Antimicrob Agents Chemother Date: 1981-01 Impact factor: 5.191

4. Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.

Authors: R N Jones; A L Barry; P C Fuchs; T L Gavan; H M Sommers; E H Gerlach
Journal: Antimicrob Agents Chemother Date: 1979-12 Impact factor: 5.191

5. Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.

Authors: R N Jones; C Thornsberry; A L Barry; R R Packer; C N Baker; R E Badal
Journal: Antimicrob Agents Chemother Date: 1980-11 Impact factor: 5.191

Enzymatic acetylation of fortimicin A and seldomycin factor 5 by aminoglycoside 3-acetyltransferase I: [AAC(3)-I] of E. coli KY8348.

1. Enzymatic modification of aminoglycoside antibiotics: 3-N-acetyltransferase with broad specificity that determines resistance to the novel aminoglycoside apramycin.

2. In vitro and in vivo antibacterial activity of KW1070, a new aminoglycoside antibiotic.

3. Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests.

4. Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.

5. Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.

6. Proposed zone standards for interpretation of fortimicin A disk diffusion tests.

7. Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.

8. In vitro and in vivo antimicrobial activities of sporaricin A, a new aminoglycoside.